| Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 21940729 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
AIMS: Mineralocorticoid receptor (MR) antagonists improve cardiovascular outcomes in patients with heart failure complicating acute myocardial infarction (AMI) and in chronic heart failure. It is unclear whether these beneficial effects are due solely to aldosterone blockade, as MR has a similar affinity for cortisol. We examined the relationships between plasma and urinary steroid hormones and left ventricular (LV) remodelling in patients with LV dysfunction following AMI. METHODS AND RESULTS: Plasma concentrations of renin, aldosterone, and N-terminal pro-brain natriuretic peptide (NT-proBNP), and 24 h urinary excretion rates of tetrahydroaldosterone (THAldo) and total cortisol metabolites were measured in 93 patients at a mean of 46 h following AMI prior to contrast-enhanced cardiac magnetic resonance (ceCMR). Patients were then randomized to 24 weeks of placebo or eplerenone therapy in addition to standard treatment, after which ceCMR was repeated. In placebo-treated patients, aldosterone, NT-proBNP, and excretion rates of THAldo and total cortisol metabolites were univariate predictors of remodelling (i.e. change in LV end-systolic volume index); aldosterone (P = 0.040) and total cortisol metabolite excretion (P = 0.038) remained independent predictors on multivariate analysis. None of the measured biomarkers predicted remodelling in the presence of eplerenone. Plasma and urinary aldosterone measures, and urinary cortisol metabolites, were not only related to larger infarct volumes and greater infarct remodelling over time, but were also higher in patients with microvascular obstruction on baseline ceCMR. CONCLUSION: Aldosterone and cortisol are associated with medium-term LV remodelling when measured early after AMI. The beneficial effects of MR antagonism may relate to blockade of both aldosterone- and cortisol-induced MR activation.ClinicalTrials.gov: NCT00132093. |
| | |
Authors:
|
Robin A P Weir; Ioannis K Tsorlalis; Tracey Steedman; Henry J Dargie; Robert Fraser; John J V McMurray; John M C Connell |
Related Documents
:
|
9476569 - Differential effects of beta-blockers in patients after recovery from myocardial infarc... 21592529 - Atrioventricular valve repair in patients with functional single-ventricle physiology: ... 18095949 - Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular di... 16640169 - Calcium channel blockers and coronary heart disease. 22770549 - Amiodarone versus lidocaine and placebo for the prevention of ventricular fibrillation ... 7670649 - Association between various drugs used for hypertension and risk of acute myocardial in... 9080169 - Cardiomyoplasty as an isolated procedure to treat refractory heart failure. 22734629 - The ecg in cardiac resynchronization therapy:: influence of left and right ventricular ... 7677539 - Complex valve operations: antegrade versus retrograde cardioplegia? |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-9-22 |
Journal Detail:
|
Title: European journal of heart failure Volume: - ISSN: 1879-0844 ISO Abbreviation: - Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-9-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100887595 Medline TA: Eur J Heart Fail Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Cardiology Department, Western Infirmary, Glasgow G11 6NT, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Peak systolic velocity indices are more sensitive than end-systolic indices in detecting contraction...
Next Document: Red cell distribution width and risk for first hospitalization due to heart failure: a population-ba...